On the other hand, ADRB2 variants were linked to insulin resistance, hyperleptinemia, obesity, and T2D, while ADRB3 variants have been associated with dyslipidaemia, obesity, and MetS [36]. Here, ADRB3 is linked to metabolic syndrome.